-
Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability-enhancing strategies
Huntjens, D. W., Béquignon, O. J. M., Krens, S. D., löwenberg, M., Chamuleau, M. E. D., Molenaar, R. J., Kramers, A. M. G., Kuijvenhoven, M. A. & Bartelink, I. H., 2025, (E-pub ahead of print) In: British Journal of Clinical Pharmacology.Research output: Contribution to journal › Article* › Academic › peer-review
-
Exclusion of Ranitidine From Premedication Regimens During Paclitaxel Treatment
Huntjens, D. W., Vanhommerig, J. W., Veen, W. V. D. & Crul, M., 18 Jan 2024, In: JAMA oncology. 10, 1, p. 131-132 2 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
Huntjens, D. W., Dijkstra, J. A., Verwiel, L. N., Slijkhuis, M., Elbers, P., Welkers, M. R. A., Veldkamp, A. I., Kuijvenhoven, M. A., de Leeuw, D. C., Abdullah-Koolmees, H., Kuipers, M. T. & Bartelink, I. H., 1 Jan 2023, In: Pharmaceutics. 15, 1, 163.Research output: Contribution to journal › Review article* › Academic › peer-review
- All publications
